| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Chief Scientific Officer | Officer Level 14 | EVP & Chief Scientific Officer +2 more
1 company
C Frank Bennett is EVP, Chief Scientific Officer at IONS. From January 2019 to August 2026, the filings on record show 0 open-market purchases and 22 sales. C Frank Bennett's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $2.4M at current prices.
Our model assigns C Frank Bennett a middling insider score of 64/100, based on 19 past trades. Over a 12-month horizon, 57.1% of those trades were profitable, with an average 12-month return of -8.5%.
The IONS filings lean toward selling, a net 389,651 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 25, 2020 | IONS Ionis Pharmaceuticals Inc | EVP, Chief Scientific Officer | Sale+OE | 15,000 | $59.77 | $896,505.00 | -31.7% | |
| Feb 1, 2019 | IONS Ionis Pharmaceuticals Inc | SVP, Antisense Research | Sale+OE | 9,013 | $58.29 | $525,367.77 | -26.9% |